Beth Wilkinson of Wilkinson Walsh + Eskovitz. (Courtesy photo)
A federal jury in New Orleans deliberated for less than two hours before coming back this week with a defense win in the first bellwether trial over the blood thinner Xarelto.
*May exclude premium content
Already have an account? Sign In Now
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to firstname.lastname@example.org to learn more.